BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12197888)

  • 1. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
    Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
    Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
    Björk E; Velloso LA; Kämpe O; Karlsson FA
    Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
    Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
    Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.
    Lohmann T; Hawa M; Leslie RD; Lane R; Picard J; Londei M
    Lancet; 2000 Jul; 356(9223):31-5. PubMed ID: 10892762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
    Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
    Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
    Daw K; Ujihara N; Atkinson M; Powers AC
    J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
    Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
    Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome.
    Butler MH; Solimena M; Dirkx R; Hayday A; De Camilli P
    J Exp Med; 1993 Dec; 178(6):2097-106. PubMed ID: 8245784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus.
    Solimena M; De Camilli P
    Trends Neurosci; 1991 Oct; 14(10):452-7. PubMed ID: 1722364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
    Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
    J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].
    Saiz A; Arias M; Fernández-Barreiro A; Mínguez A; Casamitjana R; Tolosa E; Graus F
    Med Clin (Barc); 1998 Mar; 110(10):378-81. PubMed ID: 9567281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular autoimmune responses in stiff person syndrome.
    Lohmann T; Londei M; Hawa M; Leslie RD
    Ann N Y Acad Sci; 2003 Sep; 998():215-22. PubMed ID: 14592879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus.
    Hummel M; Durinovic-Bello I; Bonifacio E; Lampasona V; Endl J; Fessele S; Then Bergh F; Trenkwalder C; Standl E; Ziegler AG
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):204-8. PubMed ID: 9703171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological disorders associated with glutamic acid decarboxylase antibodies: a Brazilian series.
    Fernandes M; Munhoz RP; Carrilho PE; Arruda WO; Lorenzoni PJ; Scola RH; Werneck LC; Teive HA
    Arq Neuropsiquiatr; 2012 Sep; 70(9):657-61. PubMed ID: 22990719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.